Sentinel Lymph Node Biopsy in Breast Cancer with Tc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer.

Tc-tilmanocept is a novel radiopharmaceutical for sentinel lymph node (SLN) biopsy in breast cancer. Our aim was to describe results with Tc-tilmanocept in a heterogeneous group of breast cancer patients scheduled for SLN biopsy. Radiotracer preparation followed the manufacturer's indications.

Selective Neck Dissection Guided by a Radioactive I125 Seed for Papillary Thyroid Carcinoma Recurrence.

Lymph nodes are the most common place of recurrence of papillary thyroid cancer, and surgery can be considered a therapeutic option. The risks of surgery increase with every intervention. We present 3 cases of cervical non palpable thyroid cancer recurrence managed with I125 seed radioguided cervical dissection from 2017 to 2019.

Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ.

Introduction: Axillary lymphadenectomy is nowadays not recommended to treat ductal carcinoma in situ (DCIS), but there is controversy surrounding the indication for sentinel lymph node biopsy (SLNB).

Materials And Methods: A prospective study of a selected group of patients diagnosed preoperatively with DCIS was performed between 2004 and 2009. Indications for SLNB were histologically determined high-grade tumours, tumour size >2 cm and patients scheduled to undergo a mastectomy.